- Home
- WFF vs CELU Comparison
WFF vs CELU Comparison
Compare WFF & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- CELU
- Stock Information
- Founded
- WFF 1984
- CELU 2016
- Country
- WFF Malaysia
- CELU United States
- Employees
- WFF N/A
- CELU N/A
- Industry
- WFF Miscellaneous manufacturing industries
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- WFF Consumer Discretionary
- CELU Health Care
- Exchange
- WFF Nasdaq
- CELU Nasdaq
- Market Cap
- WFF 44.1M
- CELU 42.2M
- IPO Year
- WFF 2025
- CELU N/A
- Fundamental
- Price
- WFF $0.95
- CELU $4.15
- Analyst Decision
- WFF
- CELU Buy
- Analyst Count
- WFF 0
- CELU 1
- Target Price
- WFF N/A
- CELU $6.00
- AVG Volume (30 Days)
- WFF 533.0K
- CELU 131.8K
- Earning Date
- WFF 01-01-0001
- CELU 10-15-2025
- Dividend Yield
- WFF N/A
- CELU N/A
- EPS Growth
- WFF N/A
- CELU N/A
- EPS
- WFF 0.00
- CELU N/A
- Revenue
- WFF $4,572,290.00
- CELU $54,220,000.00
- Revenue This Year
- WFF N/A
- CELU $23.29
- Revenue Next Year
- WFF N/A
- CELU N/A
- P/E Ratio
- WFF $199.51
- CELU N/A
- Revenue Growth
- WFF N/A
- CELU 138.11
- 52 Week Low
- WFF $0.81
- CELU $1.00
- 52 Week High
- WFF $29.26
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- CELU 71.62
- Support Level
- WFF N/A
- CELU $3.03
- Resistance Level
- WFF N/A
- CELU $3.64
- Average True Range (ATR)
- WFF 0.00
- CELU 0.29
- MACD
- WFF 0.00
- CELU 0.03
- Stochastic Oscillator
- WFF 0.00
- CELU 88.06
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.